Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism
Reference105 articles.
1. Hruska K, Mathew S, Lund R, Fang Y, Sugatani T. Cardiovascular risk factors in chronic kidney disease: does phosphate qualify? Kidney Int Suppl. 2011;(121):S9–S13. Epub 2011 Feb 23.
2. Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G. Kidney disease: improving global outcomes (KDIGO). Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006;69(11):1945–53.
3. Gutiérrez OM. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the “trade-off” hypothesis. Clin J Am Soc Nephrol. 2010;5(9):1710–6.
4. Goldsmith DJ, Cunningham J. Mineral metabolism and vitamin D in chronic kidney disease–more questions than answers. Nat Rev Nephrol. 2011;7(6):341–6.
5. Vokes TJ. Blood calcium, phosphate and magnesium. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of the mineral metabolism, vol. 6. Philadelphia: Lippincott-Raven; 2006. p. 123–7.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献